CSQ Bio® Announces CSQ Bio® – Surgical and Introduces INNESTO Rx™ Surgical Collagen Powder

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- #biologics--CSQ Bio® today announced the introduction of CSQ Bio® – Surgical, its surgical-focused business, and unveiled INNESTO Rx™, a CSQ Bio®-branded surgical collagen powder. National commercial sales of INNESTO Rx™ are scheduled to begin January 4, 2027. The underlying collagen product is FDA 510(k)-cleared. CSQ Bio® – Surgical will focus on national commercialization of surgical products, working with manufacturers and healthcare organizations on product introduct.

Business Wire • Oct 13, 2026

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

METRO CHICAGO, Ill., Oct. 1, 2026 /PRNewswire/ -- Calamos Investments®* has announced monthly distributions and sources of distributions paid in October 2026 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective distribution plans.

PRNewsWire • Oct 1, 2026

CSQ: Strong Performance, But Leverage And Fees Limit Upside

Calamos Strategic Total Return Fund is a $5.2B CEF focused on equities, convertibles, and high-yield credit, employing significant leverage. CSQ has delivered strong historical NAV returns and supports its sizable 7.8% dividend primarily through capital appreciation rather than income. Despite robust performance, I rate CSQ a Hold due to its current 7.8% discount not offering a sufficient margin of safety given 30% leverage and high fees.

Seeking Alpha • Sep 28, 2026

CSQ: Positioned For Growth In A Higher-Rate Market

Calamos Strategic Total Return Fund is rated Buy, leveraging diversified equities and fixed income with a strong tilt toward information technology and financials. CSQ's overweight in AI-driven mega-cap tech and financials positions the fund for outperformance amid a risk-on market and ongoing AI capital investment cycles. Convertible bonds and preferred stock holdings add income durability, while 30% leverage aims to amplify returns despite macroeconomic volatility.

Seeking Alpha • Sep 28, 2026

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CHW, CGO and CCD) Announce Private Placements Totaling $248.25 Million of Mandatory Redeemable Preferred Shares

METRO CHICAGO, Ill., Aug. 26, 2026 /PRNewswire/ -- The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of additional series of mandatory redeemable preferred (MRP) shares totaling $248.25 million.

PRNewsWire • Aug 26, 2026

CSQ: Trading Below Its Historical Discount

Calamos Strategic Total Return Fund remains a buy, trading at a 9.13% discount to NAV and offering a 7.8% dividend yield. CSQ's portfolio blends large-cap tech equities and income securities, but relies heavily on net realized gains to support distributions. Leverage at 27.78% and interest rate sensitivity present risks, especially if rates rise or tech sentiment shifts negatively.

Seeking Alpha • Jul 13, 2026

CSQ: Monthly Distribution Delivering Strong Returns And At A Deep Discount

Calamos Strategic Total Return Fund offers a compelling entry point with a -9.79% discount, well below its last decade historical average. CSQ has outperformed SPY over the last 10 years, driven by leverage on significant exposure to mega-cap tech and convertible securities. The fund raised its monthly distribution at the start of this year to its highest level since inception, yielding 7.18% and maintaining a tax-friendly profile.

Seeking Alpha • Jun 1, 2026

10 Best CEFs This Month: Average Yield Of 9% Plus (May 2026)

The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9% plus yield and nearly 7.5% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.

Seeking Alpha • May 23, 2026

Calamos Strategic Total Return Fund Q1 2026 Commentary

For the quarter ending March 31, 2026, Calamos Strategic Total Return Fund declined -4.69% on NAV and -9.64% on market price. Favorable security selection and an average overweight allocation in energy boosted relative returns. Security selection and an average overweight position in the information technology sector were detrimental to performance, as holdings in the systems software and communications equipment industries impeded relative returns.

Seeking Alpha • May 22, 2026

4 Closed-End Fund Buys In March 2026

I took advantage of the recent market correction to add to several closed-end fund positions, focusing on compelling discounts and long-term opportunities. Calamos Strategic Total Return Fund now trades at a double-digit discount, amplifying its appeal given its strong track record during downturns. BlackRock Utilities, Infrastructure, & Power Opportunities Trust and BlackRock Enhanced Equity Dividend Trust offer attractive entry points due to widened discounts post-rights offering for BUI and market pullback.

Seeking Alpha • Apr 15, 2026